 | |
| Clinical data | |
|---|---|
| Other names | 1-(α-Methylphenethyl)pyrrolidine; α-Methylphenethylpyrrolidine; α-Methyl-PEP; 1-(1-Methyl-2-phenylethyl)pyrrolidine |
| Drug class | Stimulant |
| ATC code |
|
| Identifiers | |
| |
| PubChemCID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C13H19N |
| Molar mass | 189.302 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
MPEP, also known as1-(α-methylphenethyl)pyrrolidine, is astimulantdrug of thephenethylamine,amphetamine, andphenylethylpyrrolidine families.[1][2] It is the α-methylderivative ofphenylethylpyrrolidine (PEP).[1][2] Notablederivatives of MPEP includeprolintane (the α-propylhomologue),α-PPP (the β-keto orcathinone derivative),α-PVP (the β-keto and α-propyl homologue),pyrovalerone (4-methyl-α-PVP), andMDPV (3,4-methylenedioxy-α-PVP), among others.[1][3] These compounds are known to act asnorepinephrine–dopamine reuptake inhibitors (NDRIs) to produce theirstimulant effects.[1][3] MPEP was first described in thescientific literature by R. V. Heinzelman and B. D. Aspergren by 1953.[1][2]
 | Thispsychoactive drug-related article is astub. You can help Wikipedia byadding missing information. |